Michael Ulz's Stock Ratings

Morgan Stanley Analyst

Michael Ulz is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

32.6%

Smart Score

Overall Average Return Percentile

88th

Number of Ratings

102

		Buy Now							Get Alert
05/13/2024	ARWR	Buy Now	Arrowhead Pharma	$24.96	8.17%	$36 → $27	Maintains	Equal-Weight	Get Alert
05/10/2024	MIRM	Buy Now	Mirum Pharmaceuticals	$24.75	114.14%	$57 → $53	Maintains	Overweight	Get Alert
04/30/2024	DYN	Buy Now	Dyne Therapeutics	$27.66	44.64%	→ $40	Initiates	→ Overweight	Get Alert
Make more informed trades with Benzinga Pro You're only getting a peek at the whole story!
04/22/2024	SLN	Buy Now	Silence Therapeutics	$23.50	91.49%	$45 → $45	Maintains	Overweight	Get Alert
04/11/2024	ALPN	Buy Now	Alpine Immune Sciences	$64.99	0.02%	$47 → $65	Downgrade	Overweight → Equal-Weight	Get Alert
03/19/2024	ALPN	Buy Now	Alpine Immune Sciences	$64.99	-27.68%	$30 → $47	Maintains	Overweight	Get Alert
03/14/2024	SLN	Buy Now	Silence Therapeutics	$23.50	91.49%	$29 → $45	Maintains	Overweight	Get Alert
03/04/2024	KYTX	Buy Now	Kyverna Therapeutics	$15.25	162.3%	→ $40	Initiates	→ Overweight	Get Alert
02/27/2024	FATE	Buy Now	Fate Therapeutics	$4.00	75%	$3 → $7	Maintains	Equal-Weight	Get Alert
02/27/2024	GUTS	Buy Now	Fractyl Health	$6.60	172.73%	→ $18	Initiates	→ Overweight	Get Alert
02/13/2024	ALNY	Buy Now	Alnylam Pharmaceuticals	$150.00	17.33%	$184 → $176	Maintains	Equal-Weight	Get Alert
02/07/2024	ARWR	Buy Now	Arrowhead Pharma	$24.96	44.23%	$34 → $36	Maintains	Equal-Weight	Get Alert
11/30/2023	ARWR	Buy Now	Arrowhead Pharma	$24.96	48.24%	$40 → $37	Maintains	Equal-Weight	Get Alert
11/29/2023	CABA	Buy Now	Cabaletta Bio	$12.64	97.78%	$28 → $25	Maintains	Overweight	Get Alert
11/13/2023	FATE	Buy Now	Fate Therapeutics	$4.00	-25%	$5 → $3	Maintains	Equal-Weight	Get Alert
11/13/2023	MIRM	Buy Now	Mirum Pharmaceuticals	$24.75	142.42%	→ $60	Initiates	→ Overweight	Get Alert
11/08/2023	CABA	Buy Now	Cabaletta Bio	$12.64	121.52%	$16 → $28	Maintains	Overweight	Get Alert
11/03/2023	IONS	Buy Now	Ionis Pharmaceuticals	$37.62	27.59%	$45 → $48	Maintains	Equal-Weight	Get Alert
11/03/2023	ALPN	Buy Now	Alpine Immune Sciences	$64.99	-53.84%	$17 → $30	Maintains	Overweight	Get Alert
11/03/2023	ALNY	Buy Now	Alnylam Pharmaceuticals	$150.00	22%	$175 → $183	Maintains	Equal-Weight	Get Alert
10/27/2023	BPMC	Buy Now	Blueprint Medicines	$104.66	-39.8%	$59 → $63	Maintains	Equal-Weight	Get Alert
10/11/2023	AKRO	Buy Now	Akero Therapeutics	$20.11	64.1%	$70 → $33	Maintains	Overweight	Get Alert
10/10/2023	ALNY	Buy Now	Alnylam Pharmaceuticals	$150.00	16.67%	$210 → $175	Maintains	Equal-Weight	Get Alert
09/27/2023	IONS	Buy Now	Ionis Pharmaceuticals	$37.62	19.62%	$42 → $45	Maintains	Equal-Weight	Get Alert
08/16/2023	ORIC	Buy Now	ORIC Pharmaceuticals	$8.97	201%	$15 → $27	Maintains	Outperform	Get Alert
08/14/2023	YMAB	Buy Now	Y-mAbs Therapeutics	$11.85	-57.81%	$7 → $5	Maintains	Underweight	Get Alert
08/11/2023	THRD	Buy Now	Third Harmonic Bio	$13.99	-49.98%	$5 → $7	Maintains	Equal-Weight	Get Alert
08/10/2023	FATE	Buy Now	Fate Therapeutics	$4.00	25%	$8 → $5	Maintains	Equal-Weight	Get Alert
08/09/2023	MRTX	Buy Now	Mirati Therapeutics	—	—	$42 → $37	Maintains	Equal-Weight	Get Alert
08/07/2023	KPTI	Buy Now	Karyopharm Therapeutics	$1.18	238.98%	$5 → $4	Maintains	Equal-Weight	Get Alert